Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors
- 8 April 2009
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 157 (1), 64-75
- https://doi.org/10.1111/j.1476-5381.2009.00152.x
Abstract
Functional interactions between the G protein-coupled dopamine D1 and histamine H3 receptors have been described in the brain. In the present study we investigated the existence of D1-H3 receptor heteromers and their biochemical characteristics. D1-H3 receptor heteromerization was studied in mammalian transfected cells with Bioluminescence Resonance Energy Transfer and binding assays. Furthermore, signalling through mitogen-activated protein kinase (MAPK) and adenylyl cyclase pathways was studied in co-transfected cells and compared with cells transfected with either D1 or H3 receptors. Bioluminescence Resonance Energy Transfer and binding assays confirmed that D1 and H3 receptors can heteromerize. Activation of histamine H3 receptors did not lead to signalling towards the MAPK pathway unless dopamine D1 receptors were co-expressed. Also, dopamine D1 receptors, usually coupled to G(s) proteins and leading to increases in cAMP, did not couple to G(s) but to G(i) in co-transfected cells. Furthermore, signalling via each receptor was blocked not only by a selective antagonist but also by an antagonist of the partner receptor. D1-H3 receptor heteromers constitute unique devices that can direct dopaminergic and histaminergic signalling towards the MAPK pathway in a G(s)-independent and G(i)-dependent manner. An antagonist of one of the receptor units in the D1-H3 receptor heteromer can induce conformational changes in the other receptor unit and block specific signals originating in the heteromer. This gives rise to unsuspected therapeutic potentials for G protein-coupled receptor antagonists.Keywords
This publication has 60 references indexed in Scilit:
- Building a new conceptual framework for receptor heteromersNature Chemical Biology, 2009
- Human adenosine deaminase as an allosteric modulator of human A1 adenosine receptor: abolishment of negative cooperativity for [3H](R)‐pia binding to the caudate nucleusJournal of Neurochemistry, 2008
- Guide to Receptors and Channels (GRAC), 3rd editionBritish Journal of Pharmacology, 2008
- D1–D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of G q /11 in the striatumProceedings of the National Academy of Sciences, 2007
- The Two-State Dimer Receptor Model: A General Model for Receptor DimersMolecular Pharmacology, 2006
- A Role for the Distal Carboxyl Tails in Generating the Novel Pharmacology and G Protein Activation Profile of μ and δ Opioid Receptor Hetero-oligomersPublished by Elsevier BV ,2005
- Dimer-based model for heptaspanning membrane receptorsTrends in Biochemical Sciences, 2005
- The histamine H receptor as a new therapeutic target for inflammationTrends in Pharmacological Sciences, 2005
- Integration of G protein signals by extracellular signal‐regulated protein kinases in SK‐N‐MC neuroepithelioma cellsJournal of Neurochemistry, 2005
- Histamine H3 receptor‐mediated inhibition of depolarization‐induced, dopamine D1 receptor‐dependent release of [3H]‐γ‐aminobutyric acid from rat striatal slicesBritish Journal of Pharmacology, 2001